News

Initial Therapy Response Refines Risk Stratification for Thyroid Cancer

Publish date: September 15, 2010

 

Dr. Castagna reported she had no financial disclosures with regard to the research.

Pages

Recommended Reading

Breast Cancer-HRT Link Confirmed in the California Teachers Study
MDedge Internal Medicine
Prophylactic Surgeries Improve Mortality in BRCA1 and BRCA2 Carriers
MDedge Internal Medicine
FDA Refuses Fast Track for Trastuzumab-DM1
MDedge Internal Medicine
Metformin May Be Key to Preventing Colorectal, Other Cancers
MDedge Internal Medicine
Adjuvant Gemcitabine Comparable to Fluorouracil for Resected Pancreatic Cancer
MDedge Internal Medicine
Two Promising Drugs Identified for Basal Cell Carcinomas
MDedge Internal Medicine
Drug Combo May Prevent Glioblastoma Recurrence
MDedge Internal Medicine
AHA: ‘Smokeless’ Tobacco Products Unsafe, Don’t Help Smokers Quit
MDedge Internal Medicine
Low-Dose Radioiodine as Effective as Higher Doses in Thyroid Remnant Ablation
MDedge Internal Medicine
Pre-Op Contact Irradiation Plus EBRT Allows Rectal Sphincter Preservation
MDedge Internal Medicine